KR850001194A - 화합물 - Google Patents

화합물 Download PDF

Info

Publication number
KR850001194A
KR850001194A KR1019840004245A KR840004245A KR850001194A KR 850001194 A KR850001194 A KR 850001194A KR 1019840004245 A KR1019840004245 A KR 1019840004245A KR 840004245 A KR840004245 A KR 840004245A KR 850001194 A KR850001194 A KR 850001194A
Authority
KR
South Korea
Prior art keywords
pyridyl
formula
compound
oxo
methyl
Prior art date
Application number
KR1019840004245A
Other languages
English (en)
Inventor
시드니 새크 죠오지
Original Assignee
데비드 마틴 워터스
스미스 클라인 앤드 프렌취 라보라토리스 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 데비드 마틴 워터스, 스미스 클라인 앤드 프렌취 라보라토리스 리미티드 filed Critical 데비드 마틴 워터스
Publication of KR850001194A publication Critical patent/KR850001194A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing alicyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Treating Waste Gases (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Impact Printers (AREA)
  • Steroid Compounds (AREA)

Abstract

내용 없음

Description

화합물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (6)

  1. 일반식(2) :
    의 화합물과 이들의 약제학상 허용 가능한 염의 제조방법.
    여기서 할(Hal)은 할로겐원자이고; R5은 아미노그룹이거나 생체내에서 아미노로 전환할 수 있는 약제학적으로 허용 가능한 이들의 유도체이고; R6는 C1-5알킬렌그룹이고; R7은 3-피리딜; N-옥소-3-피리딜; 6-메틸-3-피리딜; N-옥소-6-메틸-3-피리딜; 6-하이드록시메틸-3-피리딜; 4,6-디메틸-3-피리딜; N-옥소-4,6-디메틸-3-피리딜; 6-하이드록시메틸-4-메틸-3-피리딜; 5,6-디메틸-3-피리딜; N-옥소-5,6-디메틸-3-피리딜; 6-하이드록시-메틸-5-메틸-3-피리딜; 4-피리딜 혹은 N-옥소-4-피리딜이다.
    본 발명은 다음을 포함한다.
    화합물들은 Hal과 R6는 일반식(2)에 관하여 정의한 바와같고 R8는 아미노이거나 보호된 아미노그룹인 일반식(3)의 화합물;
    이나 이들의 염을, 일반식(4)의 화합물;
    과 반응시키는 것.
    여기에서 R7은 일반식(2)에 관하여 정의한 바와같고 R9는 아민으로 치환될 수 있는 그룹이며, 그후에는 R7은 그와같이 얻어진 일반식(2)의 화합물을, R6이 6-하이드록시메틸-3-피리딜; 6-하이드록시메틸-4-메틸-3-피리딜; 혹은 6-하이드록시메틸-5-메틸-3-피리딜인 일반식(2)의 대응하는 화합물로 전환하며 필요에 따라 R8그룹을 R5그룹으로 전환하고 임의로 그렇게 얻어진 대응하는 일반식(2)의 화합물을 약제학상 허용 가능한 염으로 전환하는 N-옥소-6-메틸-3-피리딜; N-옥소-4,6-디메틸-3-피리딜; 혹은 N-옥소-5,6-디메틸-3-피리딜이다.
    일반식(2)의 화합물은 또한 Hal, R6및 R8가 일반식(3)에 관하여 정의된 바와같은 일반식(9)의 구아니딘;
    을 R7이 일반식(4)에 관하여 정의된 바와같고, R10이 C1-4알킬(특히 에틸)벤질혹은 페닐인 일반식(10)의 화합물;
    과 반응시켜서 제조시키는 것.
    여기에서 R7은 일반식(4)에 관하여 정의된 바와같고, R10은 C1-4알킬, 벤질혹은 페닐이고 그 후에는 R7이 그렇게 얻어진 일반식(2)의 화합물을 R7이 6-하이드록시메틸-3-피리딜; 6-하이드록시메틸-4-메틸-3-피리딜; 이나 6-하이드록시메틸-5-메틸-3-피리딜은 일반식(2)의 상응하는 화합물로 전환하고 임의로 그와같이 수득한 일반식(2)의 화합물을 약제상 허용 가능한 염으로 전환하는 N-옥소-6-메틸-3-피리딜, N-옥소-4,6-디메틸-3-피리딜이나 N-옥소-5,6-디메틸-3-피리딜이다.
  2. 일반식(3)이나 (9)의 화합물에서 Hal이 브로모인 청구범위 제1항에서 청구한 바와같은 공정.
  3. 일반식(3)이나 (9)의 화합물에서 R5가 아미노인 청구범위 제1항이나 제2항에서 청구한 바와같은 공정.
  4. 일반식(3)이나 (9)의 화합물에서 R6가 에탄-1,2-디일인 청구범위 제1항 내지 제3항중의 어느 하나에서 청구한 바와같은 공정.
  5. 일반식(4)이나 (10)의 화합물에서 R7이 6-메틸피리드-3-일이나 N-옥소피리드-4-일인 청구범위 제1항 내지 제4항중의 어느 하나에서 청구한 바와같은 공정.
  6. 일반식(4)의 화합물에서 R9이 니트로 아미노인 청구범위 제1항 내지 제5항중 어느 하나에서 청구한 바와같은 공정.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019840004245A 1983-07-23 1984-07-19 화합물 KR850001194A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB838319874A GB8319874D0 (en) 1983-07-23 1983-07-23 Compounds
GB8319874 1983-07-23

Publications (1)

Publication Number Publication Date
KR850001194A true KR850001194A (ko) 1985-03-16

Family

ID=10546171

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840004245A KR850001194A (ko) 1983-07-23 1984-07-19 화합물

Country Status (23)

Country Link
US (1) US4665078A (ko)
EP (1) EP0134091B1 (ko)
JP (1) JPS6048986A (ko)
KR (1) KR850001194A (ko)
AT (1) ATE27818T1 (ko)
AU (1) AU3080984A (ko)
CS (1) CS244446B2 (ko)
DD (1) DD216463A5 (ko)
DE (1) DE3464249D1 (ko)
DK (1) DK359184A (ko)
ES (1) ES534452A0 (ko)
FI (1) FI842907A (ko)
GB (1) GB8319874D0 (ko)
GR (1) GR79961B (ko)
HU (1) HUT34745A (ko)
IL (1) IL72448A0 (ko)
JO (1) JO1326B1 (ko)
NO (1) NO842963L (ko)
NZ (1) NZ208956A (ko)
PL (1) PL248859A1 (ko)
PT (1) PT78961A (ko)
RO (1) RO89219A (ko)
ZA (1) ZA845622B (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT78358B (en) * 1983-04-07 1986-05-30 Smith Kline French Lab Chemical process
EP1087963B1 (en) 1998-06-19 2004-08-25 Chiron Corporation Inhibitors of glycogen synthase kinase 3
US7045519B2 (en) * 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
US10596401B2 (en) 2016-08-11 2020-03-24 Victaulic Company Modular valve assembly
US20180193681A1 (en) 2017-01-06 2018-07-12 Globe Fire Sprinkler Corporation Control valve assembly with test, drain and adjustable pressure relief valve
SG11202009368VA (en) 2018-03-29 2020-10-29 Victaulic Co Of America Combination control and check valve assembly for a wet piping system
EP4031788A4 (en) 2019-09-20 2023-10-18 Victaulic Company BALL VALVE ARRANGEMENT

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4154834A (en) * 1975-12-29 1979-05-15 Smith Kline & French Laboratories Limited Substituted isocytosines having histamine H2 -antagonist activity
IN151188B (ko) * 1978-02-13 1983-03-05 Smith Kline French Lab
ZW21281A1 (en) * 1980-10-01 1981-11-18 Smith Kline French Lab Amine derivatives
PT75074B (en) * 1981-06-27 1986-02-26 Smith Kline French Lab Process for preparing certain pyrimidone derivatives and compositions containing them

Also Published As

Publication number Publication date
NZ208956A (en) 1987-03-06
ES8602761A1 (es) 1985-12-01
HUT34745A (en) 1985-04-28
CS244446B2 (en) 1986-07-17
GB8319874D0 (en) 1983-08-24
NO842963L (no) 1985-01-24
FI842907A0 (fi) 1984-07-19
GR79961B (ko) 1984-10-31
PL248859A1 (en) 1985-07-16
PT78961A (en) 1984-08-01
DD216463A5 (de) 1984-12-12
JO1326B1 (en) 1986-11-30
ES534452A0 (es) 1985-12-01
ZA845622B (en) 1985-07-31
AU3080984A (en) 1985-01-24
RO89219A (ro) 1986-03-15
ATE27818T1 (de) 1987-07-15
DK359184A (da) 1985-01-24
DK359184D0 (da) 1984-07-20
CS557184A2 (en) 1985-08-15
IL72448A0 (en) 1984-11-30
EP0134091B1 (en) 1987-06-16
EP0134091A1 (en) 1985-03-13
JPS6048986A (ja) 1985-03-16
FI842907A (fi) 1985-01-24
US4665078A (en) 1987-05-12
DE3464249D1 (de) 1987-07-23

Similar Documents

Publication Publication Date Title
KR850003402A (ko) 2-아미노-5-하이드록시-4-메틸 피리미딘 유도체의 제조방법
KR850003400A (ko) 니트로메틸렌-테트라하이드로피리미딘 유도체의 제조방법
KR860001104A (ko) 테트라히드로프탈이미드의 제조방법
KR840003247A (ko) 아스코르브산 에테르 및 관련 화합물의 제조방법
KR870001192A (ko) 신규한(4-치환-피페라진일) 피리다진류의 제조방법
FI852902A0 (fi) Ny mellanprodukt och metod foer framstaellning daerav.
EP0077938A3 (en) N-(3-substituted aminophenyl) tetrahydrophthalimides and herbicidal composition
KR900016220A (ko) 매크로리드 조성물
KR850005829A (ko) 2-시아노벤즈이미다졸 유도체의 제조방법
KR840000533A (ko) 화합물의 제조방법
KR850001184A (ko) 1,5-벤조티아제핀 유도체의 제조방법
KR850001194A (ko) 화합물
KR850003719A (ko) 시아노피라졸 제초제에 대한 개량
SE7604476L (sv) Forfarande for framstellning av 1-(3,3,3-triarylpropyl)-4-fenyl-4-piperidinmetanolforeningar
KR840003631A (ko) 아졸릴펜옥시- 테트라하이드로푸란-2-일리덴- 메탄의 제조방법
KR840006254A (ko) 7-치환된-3-비닐-3-세펨화합물의 제조방법
EA199900754A1 (ru) Способ получения замещенного тиазолидиндиона
ATE14428T1 (de) Verfahren zur herstellung von bromhaltigen 1,3dioxolen-2-ones.
KR840006238A (ko) 신규 α-아릴-α-피리딜알카노인산 유도체의 제조방법
KR900000345A (ko) 1-할로 1-아졸일에탄유도체 및 이들을 함유하는 살균제
KR840001160A (ko) 벤조디옥산-이미다졸린 유도체의 제조방법
KR830005188A (ko) 혈당강하성 구아닐 아미딘의 제조방법
KR910011839A (ko) 이미다졸리딘 유도체, 그의 제조 방법 및 이를 함유하는 살충제
KR840002821A (ko) N-(2,3-에폭시프로필렌)-n-아르알킬술폰아미드 유도체의 제조방법
KR920002594A (ko) 5-이소티아졸아민 유도체

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid